TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EOLS

Evolus Inc

Healthcare · Drug Manufacturers - Specialty & Generic

7.90$ -1.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow EOLS
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-21.6% -33.1% -95.9% +55,511.1% +53.5% -17.8% -28.8% +30.5% +2.6% +45.2%
-36.7% -38.8% +1,089.6% +36.5% +11.2% -9.5% +13.1% +51.9% +35.2% -7.0%
-34.6% -734.8% -105.6% -70.5% +4.2%
-138.9% -845.2% -132.4%
+0.0% +0.0% +0.0% +50,644.4% -31.3% -69.1% +203.0% -44.6% -9.5% +474.2%
+0.0% +0.0% +0.0% +260,277.8% -67.0% -172.9% -44.6% +196.4% +75.2%
+0.0% +0.0% -81.4%
-63.5% +7.9% -127.0% -44.1% -170.0% -98.2% -100.0%
-63.5% -1.7% +811.7% +12.4% -71.3% +90.5% -105.7% +6.2% -63.4%
-82.0% -143.8% -311.3% +170.5% -237.4%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?